Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;48:473-481
Published online before print July 24, 2006, doi: 10.1161/01.HYP.0000235682.47673.ab
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
48/3/473    most recent
01.HYP.0000235682.47673.abv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gongora, M. C.
Right arrow Articles by Harrison, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gongora, M. C.
Right arrow Articles by Harrison, D. G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Animal models of human disease
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
Right arrowRelated Article

(Hypertension. 2006;48:473.)
© 2006 American Heart Association, Inc.


Original Articles

Role of Extracellular Superoxide Dismutase in Hypertension

Maria Carolina Gongora; Zhenyu Qin; Karine Laude; Ha Won Kim; Louise McCann; J. Rodney Folz; Sergey Dikalov; Tohru Fukai; David G. Harrison

From the Department of Medicine (M.C.G., Z.Q., H.W.K., L.M., S.D., T.F., D.G.H.), Division of Cardiology, Emory University School of Medicine, Atlanta, Ga; Forenap-Pharma (K.L.), Ch-Rouffach, France; and the Department of Medicine (J.R.F.), Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, NC.

Correspondence to David G. Harrison, Division of Cardiology, Emory University School of Medicine, 1639 Pierce Dr, Room 319 WMB, Atlanta, GA 30322. E-mail dharr02{at}emory.edu

We previously found that angiotensin II–induced hypertension increases vascular extracellular superoxide dismutase (ecSOD), and proposed that this is a compensatory mechanism that blunts the hypertensive response and preserves endothelium-dependent vasodilatation. To test this hypothesis, we studied ecSOD-deficient mice. ecSOD–/– and C57Blk/6 mice had similar blood pressure at baseline; however, the hypertension caused by angiotensin II was greater in ecSOD–/– compared with wild-type mice (168 versus 147 mm Hg, respectively; P<0.01). In keeping with this, angiotensin II increased superoxide and reduced endothelium-dependent vasodilatation in small mesenteric arterioles to a greater extent in ecSOD–/– than in wild-type mice. In contrast to these findings in resistance vessels, angiotensin II paradoxically improved endothelium-dependent vasodilatation, reduced intracellular and extracellular superoxide, and increased NO production in aortas of ecSOD–/– mice. Whereas aortic expression of endothelial NO synthase, Cu/ZnSOD, and MnSOD were not altered in ecSOD–/– mice, the activity of Cu/ZnSOD was increased by 80% after angiotensin II infusion. This was associated with a concomitant increase in expression of the copper chaperone for Cu/ZnSOD in the aorta but not in the mesenteric arteries. Moreover, the angiotensin II–induced increase in aortic reduced nicotinamide-adenine dinucleotide phosphate oxidase activity was diminished in ecSOD–/– mice as compared with controls. Thus, during angiotensin II infusion, ecSOD reduces hypertension, minimizes vascular superoxide production, and preserves endothelial function in resistance arterioles. We also identified novel compensatory mechanisms involving upregulation of copper chaperone for Cu/ZnSOD, increased Cu/ZnSOD activity, and decreased reduced nicotinamide-adenine dinucleotide phosphate oxidase activity in larger vessels. These compensatory mechanisms preserve large vessel function when ecSOD is absent in hypertension.


Key Words: angiotensin II • endothelium • hypertension, experimental • nitric oxide


Related Article:

Extracellular Superoxide Dismutase Depletion in Hypertension Unmasks a New Role for Angiotensin II in Regulating Cu,Zn-Superoxide Dismutase Activity
Michael S. Wolin
Hypertension 2006 48: 368-369. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
J. D. Widder, D. Fraccarollo, P. Galuppo, J. M. Hansen, D. P. Jones, G. Ertl, and J. Bauersachs
Attenuation of Angiotensin II-Induced Vascular Dysfunction and Hypertension by Overexpression of Thioredoxin 2
Hypertension, August 1, 2009; 54(2): 338 - 344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Carlstrom, R. D. Brown, J. Sallstrom, E. Larsson, M. Zilmer, S. Zabihi, U. J. Eriksson, and A. E. G. Persson
SOD1 deficiency causes salt sensitivity and aggravates hypertension in hydronephrosis
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R82 - R92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Fukai
Extracellular SOD and aged blood vessels
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H10 - H12.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. D. Lund, Y. Chu, J. D. Miller, and D. D. Heistad
Protective effect of extracellular superoxide dismutase on endothelial function during aging
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1920 - H1925.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Ryan
Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosus
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1258 - R1267.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Qin, M. C. Gongora, K. Ozumi, S. Itoh, K. Akram, M. Ushio-Fukai, D. G. Harrison, and T. Fukai
Role of Menkes ATPase in Angiotensin II-Induced Hypertension: A Key Modulator for Extracellular Superoxide Dismutase Function
Hypertension, November 1, 2008; 52(5): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. Rudolph, T. K. Rudolph, and B. A. Freeman
Copper Trafficking and Extracellular Superoxide Dismutase Activity: Kinky Hair, Kinky Vessels
Hypertension, November 1, 2008; 52(5): 811 - 812.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. C. Gongora, H. E. Lob, U. Landmesser, T. J. Guzik, W. D. Martin, K. Ozumi, S. M. Wall, D. S. Wilson, N. Murthy, M. Gravanis, et al.
Loss of Extracellular Superoxide Dismutase Leads to Acute Lung Damage in the Presence of Ambient Air: A Potential Mechanism Underlying Adult Respiratory Distress Syndrome
Am. J. Pathol., October 1, 2008; 173(4): 915 - 926.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. J. Welch
Angiotensin II-Dependent Superoxide: Effects on Hypertension and Vascular Dysfunction
Hypertension, July 1, 2008; 52(1): 51 - 56.
[Full Text] [PDF]


Home page
Diabetes CareHome page
T. M. Paravicini and R. M. Touyz
NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities
Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Lu, X. Xu, X. Hu, G. Zhu, P. Zhang, E. D. van Deel, J. P. French, J. T. Fassett, T. D. Oury, R. J. Bache, et al.
Extracellular Superoxide Dismutase Deficiency Exacerbates Pressure Overload Induced Left Ventricular Hypertrophy and Dysfunction
Hypertension, January 1, 2008; 51(1): 19 - 25.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C. Gongora and D. G. Harrison
Sad Heart From No SOD
Hypertension, January 1, 2008; 51(1): 28 - 30.
[Full Text] [PDF]


Home page
JEMHome page
T. J. Guzik, N. E. Hoch, K. A. Brown, L. A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D. G. Harrison
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction
J. Exp. Med., October 1, 2007; 204(10): 2449 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. W. Kim, A. Lin, R. E. Guldberg, M. Ushio-Fukai, and T. Fukai
Essential Role of Extracellular SOD in Reparative Neovascularization Induced by Hindlimb Ischemia
Circ. Res., August 17, 2007; 101(4): 409 - 419.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Dikalov, K. K. Griendling, and D. G. Harrison
Measurement of Reactive Oxygen Species in Cardiovascular Studies
Hypertension, April 1, 2007; 49(4): 717 - 727.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Fukai
Extracellular SOD Inactivation in High-Volume Hypertension: Role of Hydrogen Peroxide
Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 442 - 444.
[Full Text] [PDF]


Home page
HypertensionHome page
M. S. Wolin
Extracellular Superoxide Dismutase Depletion in Hypertension Unmasks a New Role for Angiotensin II in Regulating Cu,Zn-Superoxide Dismutase Activity
Hypertension, September 1, 2006; 48(3): 368 - 369.
[Full Text] [PDF]